• Post-Traumatic Stress Disorder (commonly referred to by its acronym, PTSD) is a severe anxiety disorder that can develop after exposure to any event which results in psychological trauma. This event may involve the threat of death to oneself or to someone else, or to one's own or someone else's physical, sexual, or psychological integrity, overwhelming the individual's psychological defenses.


    PTSD is a less frequent and more enduring consequence of psychological trauma than the more frequently seen acute stress response. PTSD has also been recognized in the past as railway spine, stress syndrome, shell shock, battle fatigue, traumatic war neurosis, or post-traumatic stress syndrome.


    Diagnostic symptoms include re-experiencing original trauma(s), by means of flashbacks or nightmares; avoidance of stimuli associated with the trauma; and increased arousal, such as difficulty falling or staying asleep, anger, and hyper vigilance. Formal diagnostic criteria (both DSM-IV and ICD-9) require that the symptoms last more than one month and cause significant impairment in social, occupational, or other important areas of functioning (e.g. problems with work and/or relationships).


    A study conducted at the Universitá di Firenze in Italy finds there is positive indications cannabis could help treat PTSD: "Consolidation refers to item stabilization in long-term memory. Retrieval renders a consolidated memory sensitive, and a "reconsolidation" process has been hypothesized to keep the original memory persistent. Some authors could not detect this phenomenon. Here we show that retrieved contextual fear memory is vulnerable to amnesic treatments and that the amygdala is critically involved. Cholinergic and histaminergic systems seem to modulate only consolidation, whereas cannabinoids are involved in both consolidation and reactivation. The liability of retrieved memory affords opportunities to treat disorders such as phobias, post-traumatic stress, or chronic pain, and these results help searching for appropriate therapeutic targets."

  • Category
    Critical Ailments
  • Created
    Thursday, 30 November 2017
  • Group admin
    CBIS

Become an iCannabinoid Ambassador

GET INV

Observational Studies

PART

Activity Stream

Wowwww. Guess I really do need to be in here more often! We actually need to launch this thing properly! We have most of the pieces in place now,... Show more

Osaruname Osayi-Osazuwa Thank you for the update Raymond. When is the gala? 2 days ago
loader
loader
Attachment
Margaret Gonzalez Sounds good, When will trading resume? How long is this suspension? 2 days ago
loader
loader
Attachment
Margaret Gonzalez Glad to see back up and glad to see the high was 0.02 this is great 2 hours 2 minutes ago
loader
loader
Attachment

we are already addressing this matter directly with the authorities to protect the interests of our shareholders and stakeholders,” states Raymond... Show more

Loading content, please wait.
gp wede I'm positive this news did not blindside the company and you already had a plan in place for your next step when this occurred.

Please keep us share...
Show more
2 weeks ago
loader
loader
Attachment
gp wede The Sound of Silence is Deafening 1 week ago
loader
loader
Attachment

Notifications

Events

Sorry, we currently have no events.
View All Events